Anavex Life Sciences Corp (AVXL)

[Gernee20]

When the timing is right for a partnership, if our compound shows good results, a partnership will be executed. Its all about value and timing. Getting the most out of a partnership at the optimum time. It wasn't favorable to partner in 2014, we hadn't even run a trial beyond a ph1, and the longer we go it alone and continue to show positive results, the better the partnering terms for anavex will be. As a shareholder, I am happy he has held out this long. Since 2014, we have started identifying what we have in 2-73; the safety and efficacy profiles in various indications. IMO that is the key to getting the most value out of a partnership.

Surely you will agree the farther anavex takes 2-73 in development the better the terms will be in a partnership (assuming continued positive results from our trials & R&D)?